Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CNTX Context Therapeutics Inc.

休市中 07-26 16:00:00 EDT

2.50

+0.06

+2.46%

盘后2.47

-0.03-1.20%

19:52 EDT

最高2.54	最低2.44	成交量9.86万
今开2.48	昨收2.44	日振幅4.10%
总市值1.87亿	流通市值1.10亿	总股本7,500万
成交额24.65万	换手率0.22%	流通股本4,388万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CNTX","market":"US","secType":"STK","nameCN":"Context Therapeutics Inc.","latestPrice":2.5,"timestamp":1722024000000,"preClose":2.44,"halted":0,"volume":98555,"hourTrading":{"tag":"盘后","latestPrice":2.47,"preClose":2.5,"latestTime":"19:52 EDT","volume":173,"amount":421.99,"timestamp":1722037979230},"delay":0,"floatShares":43878542,"shares":74998312,"eps":-1.335564,"marketStatus":"休市中","marketStatusCode":7,"change":0.06,"latestTime":"07-26 16:00:00 EDT","open":2.48,"high":2.54,"low":2.44,"amount":246487.64173550002,"amplitude":0.040984,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.335564,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"listingDate":1634702400000,"adjPreClose":2.44,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.48,"preClose":2.44,"latestTime":"09:09 EDT","volume":1087,"amount":2708.9212873,"timestamp":1721999348587},"postHourTrading":{"tag":"盘后","latestPrice":2.47,"preClose":2.5,"latestTime":"19:52 EDT","volume":173,"amount":421.99,"timestamp":1722037979230},"volumeRatio":1.2143749588632422},"requestUrl":"/m/hq/s/CNTX/tweets","defaultTab":"tweets","newsList":[{"id":"2452361430","title":"Context Therapeutics Inc.盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452361430","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452361430?lang=zh_cn&edition=full","pubTime":"2024-07-19 01:43","pubTimestamp":1721324626,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日01时43分，Context Therapeutics Inc.股票出现异动，股价快速拉升5.25%。截至发稿，该股报2.15美元/股，成交量5.7311万股，换手率0.08%，振幅5.39%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.66%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Silo Pharma, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为2614.87%、2505.56%、1273.97%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190143469681e214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190143469681e214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNTX","BK4007","LENZ"],"gpt_icon":0},{"id":"2452161326","title":"Context Therapeutics Inc.盘中异动 临近午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452161326","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452161326?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:36","pubTimestamp":1721230565,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时36分，Context Therapeutics Inc.股票出现异动，股价快速下跌5.08%。截至发稿，该股报2.08美元/股，成交量4.22万股，换手率0.06%，振幅5.53%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为2.04%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717233605af92cd11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717233605af92cd11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2450809812","title":"BUZZ-以 375 万美元收购实验性癌症疗法后，Context Therapeutics 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2450809812","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450809812?lang=zh_cn&edition=full","pubTime":"2024-07-10 23:33","pubTimestamp":1720625621,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    7月10日 - ** Context Therapeutics   股价上涨2.8%至2.00美元 ** 药物开发商称已从私人控股的 Link Immunotherapeutics 公司获得一种实验性癌症疗法** CNTX 一次性支付了 375 万美元** 公司将于 2025 年第一季度开始 CT-95 疗法的早期试验** 截至目前，股价上涨 77.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","LENZ","BK4139","CNTX","BK4007"],"gpt_icon":0},{"id":"2448945946","title":"Context Therapeutics Inc.盘中异动 下午盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448945946","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448945946?lang=zh_cn&edition=full","pubTime":"2024-07-02 01:48","pubTimestamp":1719856130,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日01时48分，Context Therapeutics Inc.股票出现异动，股价急速下跌5.16%。截至发稿，该股报1.90美元/股，成交量3.1873万股，换手率0.04%，振幅5.49%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702014851af900b90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702014851af900b90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CNTX","BK4007"],"gpt_icon":0},{"id":"2446823795","title":"Context Therapeutics Inc.盘中异动 临近午盘急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446823795","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446823795?lang=zh_cn&edition=full","pubTime":"2024-06-25 23:41","pubTimestamp":1719330067,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日23时41分，Context Therapeutics Inc.股票出现异动，股价大幅下挫5.05%。截至发稿，该股报2.07美元/股，成交量10.6295万股，换手率0.14%，振幅6.38%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.81%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625234107aef68a3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625234107aef68a3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","CNTX"],"gpt_icon":0},{"id":"2443678817","title":"Context Therapeutics Inc.盘中异动 股价大跌5.30%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443678817","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443678817?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:35","pubTimestamp":1718372104,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时35分，Context Therapeutics Inc.股票出现波动，股价大幅跳水5.30%。截至发稿，该股报1.87美元/股，成交量302股，换手率0.00%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061421350495b0c3c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061421350495b0c3c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2442439464","title":"Context Therapeutics Inc.盘中异动 股价大涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442439464","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442439464?lang=zh_cn&edition=full","pubTime":"2024-06-11 21:39","pubTimestamp":1718113199,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日21时39分，Context Therapeutics Inc.股票出现波动，股价快速拉升5.96%。截至发稿，该股报2.05美元/股，成交量2.0275万股，换手率0.03%，振幅6.42%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611214000af8cf48a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611214000af8cf48a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2441277062","title":"Context Therapeutics Inc.盘中异动 早盘股价大跌5.15%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441277062","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441277062?lang=zh_cn&edition=full","pubTime":"2024-06-05 22:48","pubTimestamp":1717598904,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日22时48分，Context Therapeutics Inc.股票出现波动，股价急速跳水5.15%。截至发稿，该股报1.72美元/股，成交量10.3363万股，换手率0.14%，振幅5.71%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605224825941ec986&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605224825941ec986&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","CNTX","BK4139"],"gpt_icon":0},{"id":"2440236740","title":"Context Therapeutics Inc.盘中异动 股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440236740","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440236740?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:03","pubTimestamp":1717509796,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时03分，Context Therapeutics Inc.股票出现波动，股价快速下挫5.39%。截至发稿，该股报1.93美元/股，成交量7214股，换手率0.01%，振幅2.40%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604220317af8bef47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604220317af8bef47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","CNTX"],"gpt_icon":0},{"id":"2439583102","title":"Context Therapeutics Inc.盘中异动 下午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439583102","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439583102?lang=zh_cn&edition=full","pubTime":"2024-05-29 01:21","pubTimestamp":1716916915,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日01时21分，Context Therapeutics Inc.股票出现波动，股价快速拉升5.00%。截至发稿，该股报2.10美元/股，成交量12.3407万股，换手率0.16%，振幅9.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.85%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052901215596810492&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052901215596810492&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CNTX","BK4007"],"gpt_icon":0},{"id":"2437214900","title":"Context Therapeutics Inc.盘中异动 大幅下挫6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437214900","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437214900?lang=zh_cn&edition=full","pubTime":"2024-05-23 02:10","pubTimestamp":1716401419,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日02时10分，Context Therapeutics Inc.股票出现异动，股价急速跳水6.40%。截至发稿，该股报1.90美元/股，成交量6.1006万股，换手率0.08%，振幅3.45%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405230210199680f174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405230210199680f174&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","CNTX"],"gpt_icon":0},{"id":"2435374953","title":"Context Therapeutics Inc.盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435374953","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435374953?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:52","pubTimestamp":1715611958,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时52分，Context Therapeutics Inc.股票出现异动，股价大幅下跌5.35%。截至发稿，该股报1.77美元/股，成交量6.2198万股，换手率0.08%，振幅5.35%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513225239861ecd95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513225239861ecd95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2434877327","title":"Context Therapeutics Inc.盘中异动 临近午盘急速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434877327","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434877327?lang=zh_cn&edition=full","pubTime":"2024-05-08 23:58","pubTimestamp":1715183920,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日23时58分，Context Therapeutics Inc.股票出现波动，股价大幅拉升5.23%。截至发稿，该股报1.81美元/股，成交量4.1256万股，换手率0.26%，振幅7.85%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于推动抗实体瘤药物的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508235841861ebd43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508235841861ebd43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CNTX","BK4007"],"gpt_icon":0},{"id":"2433255788","title":"Context Therapeutics Inc.盘中异动 早盘急速跳水5.01%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433255788","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433255788?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:34","pubTimestamp":1715088858,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时34分，Context Therapeutics Inc.股票出现波动，股价快速下挫5.01%。截至发稿，该股报1.69美元/股，成交量9027股，换手率0.06%，振幅1.31%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Clearmind Medicine Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nanoviricides, Inc.涨幅较大，Clearmind Medicine Inc.、Tc Biopharm  Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为933.02%、94.99%、32.52%，振幅较大的相关个股有Clearmind Medicine Inc.、Nanoviricides, Inc.、Heron Therapeutics, Inc.，振幅分别为21.37%、12.14%、11.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072134197a588573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072134197a588573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2433479361","title":"Context Therapeutics Inc.盘中异动 早盘大幅下跌5.14%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433479361","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433479361?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:30","pubTimestamp":1715002251,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时30分，Context Therapeutics Inc.股票出现异动，股价急速下跌5.14%。截至发稿，该股报1.76美元/股，成交量1.3646万股，换手率0.09%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Tc Biopharm  Plc、Effector Therapeutics Inc C/Wts 31/12/2025 、Entera Bio Ltd.涨幅较大，Allarity Therapeutics, Inc.、Tc Biopharm  Plc、Plus Therapeutics, Inc.较为活跃，换手率分别为480.33%、138.85%、39.43%，振幅较大的相关个股有Passage Bio, Inc.、Dianthus Therapeutics, Inc.、BioCryst制药，振幅分别为11.45%、7.09%、5.62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062130517a5847bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062130517a5847bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CNTX","BK4007"],"gpt_icon":0},{"id":"2426326247","title":"Context Therapeutics Inc.盘中异动 快速上涨5.19%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426326247","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426326247?lang=zh_cn&edition=full","pubTime":"2024-04-11 23:45","pubTimestamp":1712850315,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日23时45分，Context Therapeutics Inc.股票出现异动，股价快速拉升5.19%。截至发稿，该股报1.42美元/股，成交量1.7714万股，换手率0.11%，振幅5.15%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.01%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于改善患有癌症的女性的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041123451587e7fac5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041123451587e7fac5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CNTX","BK4007"],"gpt_icon":0},{"id":"2425900089","title":"Context Therapeutics Inc.盘中异动 早盘股价大涨7.88%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425900089","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2425900089?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:32","pubTimestamp":1712583168,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时32分，Context Therapeutics Inc.股票出现波动，股价快速拉升7.88%。截至发稿，该股报1.37美元/股，成交量1330股，换手率0.01%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于改善患有癌症的女性的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082132497a51664f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082132497a51664f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CNTX","BK4007"],"gpt_icon":0},{"id":"2424484639","title":"Context Therapeutics Inc.盘中异动 快速跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424484639","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424484639?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:34","pubTimestamp":1712151247,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时34分，Context Therapeutics Inc.股票出现波动，股价大幅下跌5.14%。截至发稿，该股报1.29美元/股，成交量1420股，换手率0.01%，振幅0.00%。Context Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于改善患有癌症的女性的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040321340787dae109&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040321340787dae109&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","CNTX"],"gpt_icon":0},{"id":"2424507817","title":"Context Therapeutics Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424507817","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424507817?lang=zh_cn&edition=full","pubTime":"2024-04-03 01:52","pubTimestamp":1712080356,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日01时52分，Context Therapeutics Inc.股票出现波动，股价大幅下挫5.11%。截至发稿，该股报1.30美元/股，成交量4.0589万股，换手率0.25%，振幅6.57%。Context Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.76%。Context Therapeutics Inc.公司简介：Context Therapeutics Inc 是一家临床阶段的生物制药公司，致力于改善患有癌症的女性的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403015236861e3107&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403015236861e3107&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CNTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2421486363","title":"Context Therapeutics Inc.2023财年实现净利润-23.96百万美元，同比减少61.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421486363","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421486363?lang=zh_cn&edition=full","pubTime":"2024-03-22 15:20","pubTimestamp":1711092003,"startTime":"0","endTime":"0","summary":"12月31日，Context Therapeutics Inc.公布财报，公告显示公司2023财年净利润为-23.96百万美元，同比减少61.46%；其中营业收入为0.00美元，每股基本收益为-1.50美元。机构评级：截至2023年12月31日，当前有2家机构对Context Therapeutics Inc.目标价做出预测，其中目标均价为4.00美元，其中最低目标价为4.00美元，最高目标价为4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032215481587a5e4b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032215481587a5e4b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.contexttherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1792},{"period":"1month","weight":0.2626},{"period":"3month","weight":0.7729},{"period":"6month","weight":1.5771},{"period":"1year","weight":1.2523},{"period":"ytd","weight":1.2124}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0712},{"period":"6month","weight":0.117},{"period":"1year","weight":0.2032},{"period":"ytd","weight":0.1454}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Context Therapeutics Inc.于2015年4月在特拉华州成立。这是一家临床阶段的生物制药公司，致力于改善罹患癌症的妇女的生活。肿瘤学药物开发的深远进展扩大了癌症女性可获得的治疗选择，但是治疗耐药性和复发继续限制了此类治疗的功效和持续时间。","exchange":"NASDAQ","name":"Context Therapeutics Inc.","nameEN":"Context Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Context Therapeutics Inc.(CNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Context Therapeutics Inc.,CNTX,Context Therapeutics Inc.股票,Context Therapeutics Inc.股票老虎,Context Therapeutics Inc.股票老虎国际,Context Therapeutics Inc.行情,Context Therapeutics Inc.股票行情,Context Therapeutics Inc.股价,Context Therapeutics Inc.股市,Context Therapeutics Inc.股票价格,Context Therapeutics Inc.股票交易,Context Therapeutics Inc.股票购买,Context Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Context Therapeutics Inc.(CNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Context Therapeutics Inc.(CNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}